| 06/18/2026 7:57 AM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form SCHEDULE 13D/A | |
| 06/18/2026 8:02 AM | Janus Henderson Group (1274173) Subject | Form SC 13E3/A | |
| 06/18/2026 7:44 AM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/05/2026 11:56 AM | Immix Biopharma, Inc. (1873835) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 06/05/2026 11:56 AM | Cellectar Biosciences, Inc. (1279704) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 06/02/2026 5:07 AM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/18/2026 1:07 PM | Janus Henderson Group (1274173) Filer | Form 13F-HR/A | |
| 05/15/2026 11:37 AM | Biohaven Ltd. (1935979) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | IDEAYA Biosciences, Inc. (1676725) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | Janus Henderson Group (1274173) Filed by MADRIGAL PHARMACEUTICALS, INC. (1157601) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | Janus Henderson Group (1274173) Filed by Maze Therapeutics, Inc. (1842295) Subject | Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for JHG and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Janus Henderson Group and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Vaxcyte, Inc. (1649094) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Immix Biopharma, Inc. (1873835) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Jade Biosciences, Inc. (1798749) Subject Jade Biosciences, Inc. (1798749) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Janux Therapeutics, Inc. (1817713) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Lantheus Holdings, Inc. (1521036) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:38 AM | Janus Henderson Group (1274173) Filed by Olema Pharmaceuticals, Inc. (1750284) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:39 AM | Janus Henderson Group (1274173) Filed by Protara Therapeutics, Inc. (1359931) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:39 AM | Janus Henderson Group (1274173) Filed by PTC THERAPEUTICS, INC. (1070081) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:50 AM | Janus Henderson Group (1274173) Filed by Tyra Biosciences, Inc. (1863127) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | Ascendis Pharma A/S (1612042) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BEL FUSE INC /NJ (729580) Subject BEL FUSE INC /NJ (729580) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BridgeBio Pharma, Inc. (1743881) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BRIGHT MINDS BIOSCIENCES INC. (1827401) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | BRIGHT MINDS BIOSCIENCES INC. (1827401) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | Dyne Therapeutics, Inc. (1818794) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:36 AM | Forte Biosciences, Inc. (1419041) Subject Forte Biosciences, Inc. (1419041) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | Gildan Activewear Inc. (1061894) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:37 AM | GLAUKOS Corp (1192448) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 10:42 AM | COLLEGIUM PHARMACEUTICAL, INC (1267565) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 10:42 AM | Edgewise Therapeutics, Inc. (1710072) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 10:42 AM | Janus Henderson Group (1274173) Filed by Stride, Inc. (1157408) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Janus Henderson Group (1274173) Filed by Tarsus Pharmaceuticals, Inc. (1819790) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Bicara Therapeutics Inc. (2023658) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Janus Henderson Group (1274173) Filed by Longeveron Inc. (1721484) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:43 AM | Janus Henderson Group (1274173) Filed by Minerva Neurosciences, Inc. (1598646) Subject | Form SCHEDULE 13G | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by SS&C Technologies Holdings Inc (1402436) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by Xenon Pharmaceuticals Inc. (1582313) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by Revolution Medicines, Inc. (1628171) Subject Revolution Medicines, Inc. (1628171) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | Janus Henderson Group (1274173) Filed by OSI SYSTEMS INC (1039065) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 10:23 AM | ARDELYX, INC. (1437402) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
Read this warning immediately (Ad) Porter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776.
One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift. Read Porter Stansberry's full breakdown and protect your wealth now |
| 05/15/2026 10:24 AM | Dayforce, Inc. (1725057) Subject Dayforce, Inc. (1725057) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 05/14/2026 6:35 PM | Baldwin Brian M (1728954) Reporting Janus Henderson Group (1274173) Issuer TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 6:36 PM | Frank Joshua D. (1422599) Reporting Janus Henderson Group (1274173) Issuer TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/14/2026 6:37 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form SCHEDULE 13D/A | |
| 05/13/2026 7:23 PM | Janus Henderson Group (1274173) Issuer Sheehan Anne (1776285) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:27 PM | DOLAN KEVIN B (1897219) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:28 PM | DESAI KALPANA (1899214) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:34 PM | FLOOD EUGENE JR (1598139) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:14 PM | CASSADAY JOHN M (1308732) Reporting Janus Henderson Group (1274173) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 6:59 PM | Janus Henderson Group (1274173) Issuer SEYMOUR JACKSON ANGELA (1899142) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 7:06 PM | Janus Henderson Group (1274173) Issuer Quirk Alison A. (1485499) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/13/2026 4:38 PM | Janus Henderson Group (1274173) Issuer Seidman Leslie (1595268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2026 7:02 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/08/2026 3:30 PM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/08/2026 3:32 PM | Janus Henderson Group (1274173) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/07/2026 10:29 AM | Adagene Inc. (1818838) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G | |
| 05/07/2026 10:29 AM | Janus Henderson Group (1274173) Filed by SOLENO THERAPEUTICS INC (1484565) Subject | Form SCHEDULE 13G/A | |
| 04/17/2026 8:00 AM | Janus Henderson Group (1274173) Filer | Form ARS | |
| 04/17/2026 8:00 AM | Janus Henderson Group (1274173) Filer | Form DEF 14A | |
| 04/17/2026 8:00 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 04/17/2026 7:04 AM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/13/2026 4:15 PM | Janus Henderson Group (1274173) Subject | Form SC 13E3/A | |
| 04/09/2026 3:05 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 04/07/2026 3:27 PM | Janus Henderson Group (1274173) Filed by ProMIS Neurosciences Inc. (1374339) Subject | Form SCHEDULE 13G | |
| 04/07/2026 2:48 PM | 4D Molecular Therapeutics, Inc. (1650648) Subject Janus Henderson Group (1274173) Filed by | Form SCHEDULE 13G/A | |
| 04/06/2026 5:35 PM | GREWAL SUKHDEEP SINGH (2127478) Reporting Janus Henderson Group (1274173) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/03/2026 4:00 PM | Janus Henderson Group (1274173) Filer | Form PRE 14A | |
| 03/30/2026 8:28 AM | Janus Henderson Group (1274173) Subject | Form SC 13E3/A | |
| 03/27/2026 3:30 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/26/2026 8:39 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/26/2026 10:43 AM | Janus Henderson Group (1274173) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/25/2026 3:08 PM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/25/2026 3:09 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/25/2026 7:39 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/25/2026 7:38 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/24/2026 8:54 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form SCHEDULE 13D/A | |
| 03/24/2026 4:27 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form DFAN14A | |
| 03/24/2026 4:10 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/24/2026 4:09 PM | Janus Henderson Group (1274173) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/24/2026 3:35 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/24/2026 8:20 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/24/2026 8:21 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/24/2026 8:04 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/23/2026 6:15 AM | Janus Henderson Group (1274173) Subject Victory Capital Holdings, Inc. (1570827) Filed by | Form 425 | |
| 03/20/2026 8:20 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form DFAN14A | |
| 03/20/2026 7:50 AM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form DFAN14A | |
| 03/19/2026 4:09 PM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/17/2026 6:44 AM | Janus Henderson Group (1274173) Subject Victory Capital Holdings, Inc. (1570827) Filed by | Form 425 | |
| 03/17/2026 6:27 AM | Janus Henderson Group (1274173) Subject Victory Capital Holdings, Inc. (1570827) Filed by | Form 425 | |
| 03/11/2026 4:20 PM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form DFAN14A | |
SpaceX will crumble without these 5 companies (Ad) The SpaceX IPO is drawing near, but the real opportunity may lie in 5 lesser-known companies providing the critical infrastructure SpaceX depends on to operate.
Goldman Sachs and Morgan Stanley are reportedly already building positions in one of these names. Another is a resource miner that Elon Musk's broader empire - including Tesla - relies on. Lance Ippolito has detailed all five inside his free SpaceX Investing Blackbook. Download the free SpaceX Investing Blackbook before these names go mainstream |
| 03/11/2026 4:06 PM | Janus Henderson Group (1274173) Subject Victory Capital Holdings, Inc. (1570827) Filed by | Form 425 | |
| 03/11/2026 11:41 AM | Janus Henderson Group (1274173) Issuer PODZOROV MEGAN (2048891) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/11/2026 8:51 AM | Janus Henderson Group (1274173) Subject | Form SC 13E3/A | |
| 03/11/2026 7:35 AM | Janus Henderson Group (1274173) Subject TRIAN FUND MANAGEMENT, L.P. (1345471) Filed by | Form DFAN14A | |
| 03/11/2026 7:09 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/11/2026 7:11 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/11/2026 6:51 AM | Janus Henderson Group (1274173) Filer | Form DEFA14A | |
| 03/11/2026 6:37 AM | Janus Henderson Group (1274173) Filer | Form DEFM14A | |
| 03/10/2026 10:54 AM | Janus Henderson Group (1274173) Subject PODZOROV MEGAN (2048891) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |